Long-Circulating Vasoactive 1,18-Octadecanedioic Acid-Terlipressin Conjugate

Or Berger; Wonmin Choi; Caroline H Ko; Matthew P Thompson; Michael J Avram; Daniel J Scott; Bradley L Hoare; Riley Cridge; Mark Wheatley; Ross AD Bathgate; Daniel Batlle; Nathan C Gianneschi

Journal article

Long-Circulating Vasoactive 1,18-Octadecanedioic Acid-Terlipressin Conjugate

Or Berger, Wonmin Choi, Caroline H Ko, Matthew P Thompson, Michael J Avram, Daniel J Scott, Bradley L Hoare, Riley Cridge, Mark Wheatley, Ross AD Bathgate, Daniel Batlle, Nathan C Gianneschi

ACS pharmacology & translational science | American Chemical Society | Published : 2024

DOI: 10.1021/acsptsci.3c00305

Abstract

Hepatorenal syndrome (HRS) is a life-threatening complication of end-stage liver disease first reported over a century ago, but its management still poses an unmet challenge. A therapeutic agent found to stabilize the condition is a short cyclic peptide, vasopressin analogue, terlipressin (TP). While TP is commonly prescribed for HRS patients in most parts of the world, it was only recently approved for use in the United States. TP exhibits short circulation half-lives and adverse side effects associated with the dose required. Herein, we present a 1,18-octadecanedioic acid (ODDA) conjugate of the cyclic peptide (ODDA-TP), which enables noncovalent binding to serum albumin via native fatty a..

View full abstract

University of Melbourne Researchers

Daniel Scott Author

Ross Bathgate Author

Related Projects (3)

NOVEL APPROACHES TO UNDERSTANDING PEPTIDE G-PROTEIN-COUPLED RECEPTOR ACTIVATION

G protein-coupled receptors (GPCRs) are proteins that exist on every human cell, where they sense, and respond to environmental stimuli. Bec..

STABILISING G PROTEIN-COUPLED RECEPTORS FOR DRUG DISCOVERY

Prescription drugs targeting human proteins called GPCRs are sold as effective treatments for many diseases. However, there are over 800 dif..

RESOLVING AND TARGETING THE COMPLEX MOLECULAR MECHANISMS UNDERLYING GPCR SIGNALLING

Receptors are located on the surface of all human cells to allow our cells to respond to their environment. Over 30% of prescription drugs a..

Grants

Awarded by NCI Cancer Center Support

Awarded by National Health and Medical Research Council (NHMRC) of Australia

Funding Acknowledgements

The work presented here made use of (1) The IMSERC NMR and MS facilities at Northwestern University, which have received support from the Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF ECCS-2025633), and Northwestern University; and (2) The Keck Biophysics Facility, a shared resource of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University supported in part by the NCI Cancer Center Support grant no. P30 CA060553. Work at the Florey Institute was supported by the National Health and Medical Research Council (NHMRC) of Australia project grant nos.1081801 (D.J.S.), 1081844, and 1141034 (D.J.S. and R.A.D.B.), an NHMRC Fellowship (R.A.D.B.), a NHMRC Boosting Dementia Research Leadership Fellowship (to D.J.S.), and the Victorian Government's Operational Infrastructure Support Program. We thank Sharon Layfield and Tania Ferraro for technical assistance, and we would like to acknowledge the Melbourne Cytometry Platform for assistance with flow cytometry. N.C.G. would like to thank Northwestern University for financial support and for aiding in the study design for the experiments conducted at external CROs (IRBM S.p.A. Pomezia RM, Italy, and WuXi AppTec Co., Ltd. Shanghai, China) through the NewCures Accelerator program.